Targeting the Fas/Fas ligand pathway in cancer

By O’Brien Darren I   Nally Ken   Kelly Raymond G   O’Connor Terrence M   Shanahan Fergus   O’Connell Joe  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1031-1044

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Interleukin-10 on the Expression of Fas and FasL in Rat Hepatic Stellate Cells

By  

Medicinal Chemistry, Vol. 2, Iss. 6, 2006-11 ,pp. : 611-616

Bentham Science Publishers

Access to resources Recommend Favorite

Fas-Associated Protein with Death Domain Regulates Notch Signaling during Muscle Regeneration

By  

Cells Tissues Organs, Vol. 200, Iss. 3-4, 2015-08 ,pp. : 253-264

Karger

Access to resources Recommend Favorite

Activated T Cells and Soluble Molecules in the Portal Venous Blood of Patients with Cholestatic and Hepatitis C Virus-positive Liver Cirrhosis. Possible Promotion of Fas/FasL-mediated Apoptosis in the Bile-duct Cells and Hepatocyte Injury

By Ariki N   Morimoto Y   Yagi T   Oyama T   Cyouda Y   Sadamori H   Inagaki M   Urushihara N   Iwagaki H   Tanaka N  

The Journal of International Medical Research, Vol. 31, Iss. 3, 2003-05 ,pp. : 170-180

Field House Publishing

Access to resources Recommend Favorite

Functional Expression of Fas and Fas Ligand on Human Colonic Intraepithelial T Lymphocytes

By Hongo T   Morimoto Y   Iwagaki H   Kobashi K   Yoshii M   Urushihara N   Hizuta A   Tanaka N  

The Journal of International Medical Research, Vol. 28, Iss. 3, 2000-05 ,pp. : 132-142

Field House Publishing

Access to resources Recommend Favorite